Dr. Lisa Shubitz works on a live, avirulent mutant vaccine to prevent Valley Fever in dogs and people; mouse modeling of coccidioidomycosis to study host immunity, vaccine responses, fungal pathogenesis, immunogenetic susceptibility, and test potential new therapeutics. Dr. Shubitz also does clinical research, mainly in dogs, that help improve clinical care, such as investigation of diagnostic tests and therapeutics as well as the Canine Valley Fever Vaccine. She also consults on veterinary Valley Fever cases, which assists in translational aspects of research into clinical practice.
Document
